BMRN 8-K 2026-09-30

BIOMARIN PHARMACEUTICAL INC (BMRN) 8-K dated 2026-09-30 — accession 0001628280-26-063981. This URL is the filing, not the BMRN hub.

BIOMARIN PHARMACEUTICAL INC (BMRN) is a biotechnology company listed on NASDAQ.

BIOMARIN PHARMACEUTICAL INC filed a 8-K on 2026-09-30. Accession 0001628280-26-063981.

Cached items: 1.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BMRN revenue for 2025-12-31 was $3.22B. Net income was $348.9M. Revenue was up 12.9% from 2024-12-31 to 2025-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.

Not investment advice. The BMRN SEC hub lists recent forms. The stock page is the research view.